Xiangyu Medical Co.,Ltd (SHA:688626)
China
· Delayed Price · Currency is CNY 64.14
-0.27 (-0.42%)
Mar 10, 2026, 1:04 PM CST
Xiangyu Medical Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | - | 102.94 | 227.14 | 125.47 | 201.9 | Upgrade
|
| Depreciation & Amortization | - | 37.95 | 18.08 | 16.06 | 11.37 | Upgrade
|
| Other Amortization | - | 3.99 | 1.51 | 1.63 | 0.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.07 | -0.01 | - | -0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.05 | 0.02 | 0.25 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -1.4 | -6.06 | -12.59 | -12.13 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 3.19 | 2.15 | 0.07 | 2.2 | Upgrade
|
| Other Operating Activities | - | 13.66 | 13.49 | 3.03 | 0.49 | Upgrade
|
| Change in Accounts Receivable | - | -20.71 | -44.14 | 18.03 | -31.44 | Upgrade
|
| Change in Inventory | - | -6 | -27.68 | -65.8 | -29.31 | Upgrade
|
| Change in Accounts Payable | - | 38.23 | 48.4 | 94.37 | 23.84 | Upgrade
|
| Change in Other Net Operating Assets | - | 5.1 | 2.83 | - | - | Upgrade
|
| Operating Cash Flow | - | 178.59 | 227.91 | 186.7 | 165.88 | Upgrade
|
| Operating Cash Flow Growth | - | -21.64% | 22.07% | 12.55% | -23.35% | Upgrade
|
| Capital Expenditures | - | -438.89 | -479.26 | -203.07 | -133.91 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.08 | 0.09 | 0.07 | 0.04 | Upgrade
|
| Divestitures | - | - | 0.23 | - | - | Upgrade
|
| Investment in Securities | - | 161.8 | 232.42 | 5.42 | -657.2 | Upgrade
|
| Other Investing Activities | - | 1.26 | 11.98 | 18.68 | 9.03 | Upgrade
|
| Investing Cash Flow | - | -275.76 | -234.54 | -178.9 | -782.04 | Upgrade
|
| Short-Term Debt Issued | - | 516 | 82 | 60.15 | - | Upgrade
|
| Total Debt Issued | - | 516 | 82 | 60.15 | - | Upgrade
|
| Short-Term Debt Repaid | - | -202.68 | -73.3 | -47.78 | -50.09 | Upgrade
|
| Long-Term Debt Repaid | - | -1.51 | -1.09 | - | - | Upgrade
|
| Total Debt Repaid | - | -204.18 | -74.38 | -47.78 | -50.09 | Upgrade
|
| Net Debt Issued (Repaid) | - | 311.82 | 7.62 | 12.37 | -50.09 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,086 | Upgrade
|
| Repurchase of Common Stock | - | -77.57 | -25.66 | -73.27 | - | Upgrade
|
| Common Dividends Paid | - | -85.59 | -40.46 | -59.94 | -59.41 | Upgrade
|
| Other Financing Activities | - | -0.28 | - | 3.8 | -21.08 | Upgrade
|
| Financing Cash Flow | - | 148.38 | -58.5 | -117.04 | 955.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.07 | -0.02 | -0.02 | -0.02 | Upgrade
|
| Net Cash Flow | - | 51.15 | -65.15 | -109.27 | 338.95 | Upgrade
|
| Free Cash Flow | - | -260.3 | -251.35 | -16.37 | 31.97 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -58.31% | Upgrade
|
| Free Cash Flow Margin | - | -35.01% | -33.75% | -3.35% | 6.11% | Upgrade
|
| Free Cash Flow Per Share | - | -1.67 | -1.59 | -0.10 | 0.21 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.19 | - | Upgrade
|
| Cash Income Tax Paid | - | 44.21 | 58.42 | 43.73 | 62.21 | Upgrade
|
| Levered Free Cash Flow | - | -346.73 | -391.43 | -65.55 | -56.43 | Upgrade
|
| Unlevered Free Cash Flow | - | -344.46 | -389.77 | -65.43 | -56.43 | Upgrade
|
| Change in Working Capital | - | 18.28 | -28.42 | 52.78 | -38.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.